Status:
TERMINATED
Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy
Lead Sponsor:
Emory University
Conditions:
Appendicitis
Surgery
Eligibility:
All Genders
2-17 years
Phase:
PHASE4
Brief Summary
This study is designed as a randomized controlled trial with patients assigned to neuromuscular reversal with either sugammadex or neostigmine/glycopyrrolate reversal. The study will not be blinded to...
Detailed Description
Patients presenting to the operating room for laparoscopic appendectomy with a diagnosis of acute appendicitis require rapid sequence induction (RSI) due to significant vomiting and concern for increa...
Eligibility Criteria
Inclusion
- Patients 2-17 years of age
- Diagnosis of acute appendicitis
- Patient undergoing laparoscopic appendectomy at Children's Healthcare of Atlanta- Egleston.
- Parent or Legal Authorized Representative willing to participate, able to understand and sign an informed consent
Exclusion
- Patient with an allergy to Sugammadex or Neostigmine
- History of renal dysfunction
- Parent or legal guardian unwilling or unable or unable to understand the informed consent
Key Trial Info
Start Date :
July 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2024
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05256901
Start Date
July 19 2023
End Date
August 5 2024
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30329